{
  "id": "ef826dadf5e4c11c",
  "title": "STAT+: Results in Terns leukemia drug study suggest it could be a successor to Novartis blockbuster",
  "description": "Terns Pharmaceuticals reports its targeted leukemia drug maintained and even boosted molecular response rates in advanced-stage patients.",
  "content": "Terns Pharmaceuticals reports its targeted leukemia drug maintained and even boosted molecular response rates in advanced-stage patients.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/2025/12/08/terns-leukemia-drug-ash-results-tern-701/?utm_campaign=rss",
  "published_at": "2025-12-08T19:45:00+00:00",
  "fetched_at": "2025-12-09T00:22:19.510482+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "drug",
    "ai"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: Results in Terns leukemia drug study suggest it could be a successor to Novartis blockbuster",
    "description": "Terns Pharmaceuticals reports its targeted leukemia drug maintained and even boosted molecular response rates in advanced-stage patients.",
    "url": "https://www.statnews.com/2025/12/08/terns-leukemia-drug-ash-results-tern-701/?utm_campaign=rss",
    "published": "2025-12-08T19:45:00+00:00",
    "source": "STAT"
  }
}